Tumor regressions observed in patients w
โ
Marie Marchand; Nicolas van Baren; Patrick Weynants; Vincent Brichard; Brigitte
๐
Article
๐
1999
๐
John Wiley and Sons
๐
French
โ 886 KB
Thirty-nine tumor-bearing patients with metastatic melanoma were treated with 3 subcutaneous injections of the MAGE-3.A1 peptide at monthly intervals. No significant toxicity was observed. Of the 25 patients who received the complete treatment, 7 displayed significant tumor regressions. All but one